Immune thrombocytopenia (ITP)

Immune thrombocytopenia affects platelets, the cell fragments that help blood clot. The condition involves a misdirected immune response in which antiplatelet antibodies and immune cells clear platelets from circulation faster than normal, and current understanding also points to impaired platelet production in the bone marrow as a contributing factor rather than destruction alone. It can follow an infection, occur on its own, or appear alongside other autoimmune conditions.

ITP is uncommon and research estimates its prevalence at roughly 9 to 20 cases per 100,000 people, with incidence rising with age and a modest tendency to affect women somewhat more than men. Severity ranges widely, and many people with only mildly low platelet counts have few or no symptoms, while others experience more significant bleeding risk.

Common signs

Easy or unusual bruising, tiny reddish-purple dots on the skin (petechiae), bleeding gums, frequent nosebleeds, heavier menstrual bleeding, and blood in urine or stool. Many people have few or no symptoms when counts are only mildly low.

This is a plain-language summary for orientation, not a diagnosis. Mechanisms are described as current understanding, not settled fact. Work with your own clinician for your care.